First National Bank of South Miami’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$56.6K Hold
600
0.05% 179
2023
Q1
$49.6K Hold
600
0.04% 188
2022
Q4
$45K Hold
600
0.03% 198
2022
Q3
$50K Hold
600
0.04% 187
2022
Q2
$57K Sell
600
-36
-6% -$3.73K 0.04% 193
2022
Q1
$75K Hold
636
0.05% 198
2021
Q4
$83K Hold
636
0.05% 193
2021
Q3
$72K Hold
636
0.05% 184
2021
Q2
$66K Hold
636
0.05% 191
2021
Q1
$53K Hold
636
0.04% 189
2020
Q4
$58K Buy
636
+36
+6% +$2.99K 0.05% 176
2020
Q3
$48K Hold
600
0.05% 171
2020
Q2
$41K Hold
600
0.04% 171
2020
Q1
$38K Hold
600
0.05% 164
2019
Q4
$47K Hold
600
0.05% 169
2019
Q3
$44K Hold
600
0.04% 183
2019
Q2
$43K Hold
600
0.04% 186
2019
Q1
$38K Hold
600
0.04% 194
2018
Q4
$34K Buy
+600
New +$30.4K 0.03% 198

Other funds holding EW

First National Bank of South Miami's EW Position: Q2 2023 in Review

First National Bank of South Miami held its Edwards Lifesciences (EW) position steady in Q2 2023 at 600 shares worth $56.6K. The position accounts for 0.05% of the portfolio, ranked #179.

First National Bank of South Miami first reported a position in EW in Q4 2018 and has held it in 19 quarters since. The position peaked at $83K in Q4 2021. 1,279 funds tracked by Wall St. Rank hold EW as of Q2 2023.

  • First National Bank of South Miami held 600 shares of Edwards Lifesciences worth $56.6K as of Q2 2023.
  • First National Bank of South Miami left its Edwards Lifesciences share count unchanged in Q2 2023.
  • Edwards Lifesciences made up 0.05% of First National Bank of South Miami's portfolio in Q2 2023, its #179 holding.
  • First National Bank of South Miami first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 19 quarters since.
  • First National Bank of South Miami's Edwards Lifesciences position peaked at $83K in Q4 2021.
  • 1,279 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2023.

Based on First National Bank of South Miami's 13F filing for Q2 2023, filed 12 Jul 2023.